Characterization of Circulating Human Osteoclast Progenitors: Development of In Vitro Resorption Assay
Authors:
- 7 February 2005
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 76 (3) , 222-230
Abstract
Several cell surface markers were used to isolate monocytes as osteoclast progenitors with an immunomagnetic cell separation system. Use of this system with specific monocyte antibodies produced 99% pure monocytes. When purified monocytes were cultured on bovine bone slices in the presence of receptor activator of nuclear factor-κB (RANKL), macrophage-colony stimulating factor (M-CSF), tumor necrocis factor alpha (TNF-α), and dexamethasone for 14 days, CD14+ CD11b+, and CD61+ monocytes had approximately 90-, 30- and 20-fold higher osteoclast formation capacities/plated cells compared to the control culture. CD15+ monocytes generated few tartrate-resistant acid phosphatase-positive multinucleated cells (TRACP+ MNC), and CD169+ monocytes generated no TRACP+ MNC. This suggests, that there are various subsets of monocytes in the blood circulation and that they have different capacities in osteoclast formation. These results show that circulating human osteoclast progenitors can be efficiently purified by immunomagnetic cell separation system using anti-CD14, -CD11b, and -CD61 antibodies. These purified monocyte fractions had different ability to give rise to osteoclasts. CD169 was not found to be suitable for osteoclast progenitor isolation. Optimal concentration of dexamethasone for osteoclast formation and bone resorption was 10 nM. To develop a human resorption assay, osteoclasts were first induced for 7 days, whole media were replaced, cultures were continued for additional 3 days and C-terminal telopeptide of type I collagen was determined from culture media. This assay was shown to be functional, since two well-known resorption inhibitors, bafilomycin A1 and calcitonin, dose-dependently inhibited the resorption activity of osteoclasts.Keywords
This publication has 59 references indexed in Scilit:
- Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursorsJournal of Cellular Biochemistry, 1999
- Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.Proceedings of the National Academy of Sciences, 1996
- Osteoclast DifferentiationCritical Reviews in Oral Biology & Medicine, 1991
- Generation of osteoclasts from hemopoietic cells and a multipotential cell line in vitroJournal of Cellular Physiology, 1989
- Osteoclast formation from cloned pluripotent hemopoietic stem cellsBone and Mineral, 1989
- In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell populationNature, 1986
- Successful Bone-Marrow Transplantation for Infantile Malignant OsteopetrosisNew England Journal of Medicine, 1980
- Investigation of cell lineage in bone using a chimaera of chick and quail embryonic tissueNature, 1975
- Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants.Journal of Experimental Medicine, 1975
- Osteopetrosis Cured by Temporary ParabiosisScience, 1973